| Antigen | 17- aa peptide of Human NLGN4 (Protein accession # Q8N0W4; ref. 1); designated as NLGN41-P control/blocking peptide conjugated to KLH; epitope location ~ C-terminus, extracellular |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | Human NLGN41-P peptide sequence is unique to human NLGN4 protein sequence with no known counterpart in mouse or rat. Antibody cross-reactivity in various species is not known. The control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |